IPEC Chairman Dave Schoneker discusses current efforts toward facilitating regulatory reviews of new excipients.

Clear labels for substances that can be used as excipients, APIs, or both are critical to end-product use.

The less complex nature of excipient manufacturers, as compared with API manufactures, carries many benefits.

A changing regulatory environment is on the horizon for excipient suppliers and users.